YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Eric Schadt: Why Biology Needs a Steve Jobs


August 10, 2012 | Merck. Sage. Pacific Biosciences. Eric Schadt's unconventional career has seen him land in 2011 as chair of the Mount Sinai School of Medicine's Department of Genetics and Genomics and director of the new Institute for Genomics and Multiscale Biology. In this interview, Schadt discusses his vision to spend $100 million launching Mount Sinai to the forefront of the genomics revolution—and why he's enlisting Wall Street quants, user interface gurus and Facebook's former data whiz to do it. Nature Biotechnology
Click here to login and leave a comment.  

1 Comments

  • Avatar

    Fascinating interview. However, considering what happened to the US economy in 2008, I'm not sure I'd use Wall Street quants as a beneficial example. They missed the one prediction that could have made difference. It was kind of an elephant in the living room.

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.